Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 98.0819 USD 0.26%
Market Cap: 4.7B USD
Have any thoughts about
Axsome Therapeutics Inc?
Write Note

Gross Margin
Axsome Therapeutics Inc

90.3%
Current
62%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
90.3%
=
Gross Profit
263.2m
/
Revenue
291.5m

Gross Margin Across Competitors

Country US
Market Cap 4.7B USD
Gross Margin
90%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 761.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 368.4B USD
Gross Margin
69%
Country US
Market Cap 250.9B USD
Gross Margin
77%
Country CH
Market Cap 208.8B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 158.6B GBP
Gross Margin
82%
Country IE
Market Cap 155B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Axsome Therapeutics Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
90.3%
=
Gross Profit
263.2m
/
Revenue
291.5m
What is the Gross Margin of Axsome Therapeutics Inc?

Based on Axsome Therapeutics Inc's most recent financial statements, the company has Gross Margin of 90.3%.